Articles: surgery.
-
Multicenter Study Observational Study
Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy.
There is little evidence on the impact of current recommendations on the use of antiplatelet therapy during the perioperative and periprocedural period in our setting. The aim of this study was to analyze the incidence and clinical impact of inappropriate use of antiplatelet therapy in a population of patients undergoing surgery or a diagnostic or therapeutic procedure in "real life" in Spain. ⋯ Despite current recommendations for the use of antiplatelet drugs in the perioperative/periprocedural period, their implementation in the "real world" remains low. Inappropriate use is associated with an increased incidence of adverse events, both thrombotic and hemorrhagic.
-
Retrospective cohort. ⋯ Most patients achieved cost-effectiveness after four years postoperatively, with 56% meeting at five years postoperatively. When revision was avoided, 87% of patients met cumulative cost-effectiveness till life expectancy. Mechanical complications were predictive of failure to achieve cost-effectiveness at two years, while comorbidity burden and medical complications were at five years.
-
Retrospective cohort study. ⋯ III.
-
Retrospective database review. ⋯ Level II.
-
Retrospective cohort study. ⋯ Level III.